GlassScriptPhysician profile
Hilda Diaz
NPI 1114477395
$3,307.84
in general payments reported to CMS, 2019-2025
12 companies · $1,188 in 2025
The $1,188 reported for 2025 was more than what 90% of Acute Care (Nurse Practitioner) providers received nationally (typical 2025 total: $151).
See the full distribution for Acute Care (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $29.06 · 2022: $227 · 2023: $1,420 · 2024: $444 · 2025: $1,188.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,902 · Travel and Lodging: $771 · Education: $379.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,901.72 |
| Travel and Lodging | $771.47 |
| Education | $378.97 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $839.64 | 2025 | General - Therapies, Enroute Transcarotid Neuroprotection System, Spyglass Discover |
| Silk Road Medical, INC. | $823.63 | 2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Astellas Pharma US INC | $502.76 | 2023-2024 | Veozah |
| Actelion Pharmaceuticals US, INC. | $266.29 | 2022-2023 | Uptravi, Opsumit |
| Angiodynamics, INC. | $223.70 | 2024-2025 | Auryon Laser System 100-120 Vac |
| Medtronic, INC. | $208.87 | 2024-2025 | Venaseal, Corevalve Evolut R |
| Abbvie INC. | $185.47 | 2021-2023 | |
| Merck Sharp & Dohme LLC | $99.94 | 2024 | Prevymis |
| United Therapeutics Corporation | $87.29 | 2022-2023 | Orenitram, Tyvaso, Remodulin |
| Merit Medical Systems INC | $31.43 | 2025 | Surfacer Inside-Out Catheter |
| Atricure, INC. | $25.57 | 2025 | Synergy Ablation System, Atriclip Laa Exclusion System |
| Pacira Pharmaceuticals Incorporated | $13.25 | 2024 | Exparel |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hilda Diaz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.